214 related articles for article (PubMed ID: 20956458)
41. The expression of AIP-related molecules in elucidation of cellular pathways in pituitary adenomas.
Heliövaara E; Raitila A; Launonen V; Paetau A; Arola J; Lehtonen H; Sane T; Weil RJ; Vierimaa O; Salmela P; Tuppurainen K; Mäkinen M; Aaltonen LA; Karhu A
Am J Pathol; 2009 Dec; 175(6):2501-7. PubMed ID: 19850893
[TBL] [Abstract][Full Text] [Related]
42. Low rate of germline AIP mutations in patients with apparently sporadic pituitary adenomas before the age of 40: a single-centre adult cohort.
Preda V; Korbonits M; Cudlip S; Karavitaki N; Grossman AB
Eur J Endocrinol; 2014 Nov; 171(5):659-66. PubMed ID: 25184284
[TBL] [Abstract][Full Text] [Related]
43. Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors.
Marques P; Caimari F; Hernández-Ramírez LC; Collier D; Iacovazzo D; Ronaldson A; Magid K; Lim CT; Stals K; Ellard S; Grossman AB; Korbonits M;
J Clin Endocrinol Metab; 2020 Jun; 105(6):e2247-60. PubMed ID: 31996917
[TBL] [Abstract][Full Text] [Related]
44. Germline RET mutations in exons 10 and 11: an Iranian survey of 57 medullary thyroid carcinoma cases.
Hedayati M; Nabipour I; Rezaei-Ghaleh N; Azizi F
Med J Malaysia; 2006 Dec; 61(5):564-9. PubMed ID: 17623957
[TBL] [Abstract][Full Text] [Related]
45. Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre.
Bugalho MJ; Domingues R; Santos JR; Catarino AL; Sobrinho L
Surgery; 2007 Jan; 141(1):90-5. PubMed ID: 17188172
[TBL] [Abstract][Full Text] [Related]
46. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.
Zhou Y; Zhao Y; Cui B; Gu L; Zhu S; Li J; Liu J; Yin M; Zhao T; Yin Z; Yu C; Chen C; Wang L; Xiao B; Hong J; Zhang Y; Tang Z; Wang S; Li X; Ning G
Clin Endocrinol (Oxf); 2007 Oct; 67(4):570-6. PubMed ID: 17573899
[TBL] [Abstract][Full Text] [Related]
47. Genome-wide scan identifies novel modifier loci of acromegalic phenotypes for isolated familial somatotropinoma.
Khoo SK; Pendek R; Nickolov R; Luccio-Camelo DC; Newton TL; Massie A; Petillo D; Menon J; Cameron D; Teh BT; Chan SP
Endocr Relat Cancer; 2009 Sep; 16(3):1057-63. PubMed ID: 19443539
[TBL] [Abstract][Full Text] [Related]
48. The genetics of pituitary adenomas.
Vandeva S; Jaffrain-Rea ML; Daly AF; Tichomirowa M; Zacharieva S; Beckers A
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):461-76. PubMed ID: 20833337
[TBL] [Abstract][Full Text] [Related]
49. Frequency of AIP gene mutations in young patients with acromegaly: a registry-based study.
Schöfl C; Honegger J; Droste M; Grussendorf M; Finke R; Plöckinger U; Berg C; Willenberg HS; Lammert A; Klingmüller D; Jaursch-Hancke C; Tönjes A; Schneidewind S; Flitsch J; Bullmann C; Dimopoulou C; Stalla G; Mayr B; Hoeppner W; Schopohl J
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2789-93. PubMed ID: 25093619
[TBL] [Abstract][Full Text] [Related]
50. Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation.
Williams F; Hunter S; Bradley L; Chahal HS; Storr HL; Akker SA; Kumar AV; Orme SM; Evanson J; Abid N; Morrison PJ; Korbonits M; Atkinson AB
J Clin Endocrinol Metab; 2014 Apr; 99(4):1122-31. PubMed ID: 24423289
[TBL] [Abstract][Full Text] [Related]
51. Study of major genetic factors involved in pituitary tumorigenesis and their impact on clinical and biological characteristics of sporadic somatotropinomas and non-functioning pituitary adenomas.
Foltran RK; Amorim PVGH; Duarte FH; Grande IPP; Freire ACTB; Frassetto FP; Dettoni JB; Alves VA; Castro I; Trarbach EB; Bronstein MD; Jallad RS
Braz J Med Biol Res; 2018 Jun; 51(9):e7427. PubMed ID: 29947650
[TBL] [Abstract][Full Text] [Related]
52. Screening for AIP gene mutations in a Han Chinese pituitary adenoma cohort followed by LOH analysis.
Cai F; Zhang YD; Zhao X; Yang YK; Ma SH; Dai CX; Liu XH; Yao Y; Feng M; Wei JJ; Xing B; Jiao YH; Wei ZQ; Yin ZM; Zhang B; Gu F; Wang RZ
Eur J Endocrinol; 2013 Dec; 169(6):867-84. PubMed ID: 24050928
[TBL] [Abstract][Full Text] [Related]
53. Risk category system to identify pituitary adenoma patients with
Caimari F; Hernández-Ramírez LC; Dang MN; Gabrovska P; Iacovazzo D; Stals K; Ellard S; Korbonits M;
J Med Genet; 2018 Apr; 55(4):254-260. PubMed ID: 29440248
[TBL] [Abstract][Full Text] [Related]
54. Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations.
Jaffrain-Rea ML; Rotondi S; Turchi A; Occhi G; Barlier A; Peverelli E; Rostomyan L; Defilles C; Angelini M; Oliva MA; Ceccato F; Maiorani O; Daly AF; Esposito V; Buttarelli F; Figarella-Branger D; Giangaspero F; Spada A; Scaroni C; Alesse E; Beckers A
Endocr Relat Cancer; 2013 Oct; 20(5):753-66. PubMed ID: 23940012
[TBL] [Abstract][Full Text] [Related]
55. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
[TBL] [Abstract][Full Text] [Related]
56. Functional characterization of the MTC-associated germline RET-K666E mutation: evidence of oncogenic potential enhanced by the G691S polymorphism.
Borrello MG; Aiello A; Peissel B; Rizzetti MG; Mondellini P; Degl'Innocenti D; Catalano V; Gobbo M; Collini P; Bongarzone I; Pierotti MA; Greco A; Seregni E
Endocr Relat Cancer; 2011 Aug; 18(4):519-27. PubMed ID: 21690267
[TBL] [Abstract][Full Text] [Related]
57. A novel Czech kindred with familial medullary thyroid carcinoma and Hirschsprung's disease.
Dvoráková S; Dvoráková K; Malíková M; Skába R; Vlcek P; Bendlová B
J Pediatr Surg; 2005 Jun; 40(6):e1-6. PubMed ID: 15991157
[TBL] [Abstract][Full Text] [Related]
58. Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects.
Pepe S; Korbonits M; Iacovazzo D
J Endocrinol; 2019 Feb; 240(2):R21-R45. PubMed ID: 30530903
[TBL] [Abstract][Full Text] [Related]
59. Do the aryl hydrocarbon receptor interacting protein variants (Q228K and Q307R) play a role in patients with familial and sporadic hormone-secreting pituitary adenomas?
Yarman S; Ogret YD; Oguz FS
Genet Test Mol Biomarkers; 2015 Jul; 19(7):394-8. PubMed ID: 25938168
[TBL] [Abstract][Full Text] [Related]
60. A novel C-terminal nonsense mutation, Q315X, of the aryl hydrocarbon receptor-interacting protein gene in a Japanese familial isolated pituitary adenoma family.
Iwata T; Yamada S; Ito J; Inoshita N; Mizusawa N; Ono S; Yoshimoto K
Endocr Pathol; 2014 Sep; 25(3):273-81. PubMed ID: 24789813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
